The region's expertise in vaccines and infectious disease is closely linked with its strengths in biomanufacturing.
The Royal Liverpool & Broadgreen University NHS Trust along with its partners University of Liverpool and the Liverpool School of Tropical Medicine were awarded a specialist Biomedical Research Centre in Microbial Disease. This award was made following a competitive bidding process. It was in recognition of the research excellence within the field in the city.
Liverpool School of Tropical Medicine is the oldest such school in the world. LSTM is an international postgraduate centre of excellence, devoted to research, education and training, and consultancy. LSTM has a portfolio of research based in the developing countries of the tropics. This is run alongside laboratory-based programmes, particularly in the area of parasitic and other communicable diseases.
Novartis Vaccines in Speke manufactures an extensive range of products including: Begrivac™, the first preservative-free vaccine; Encepur™, a vaccine against tick-borne encephalitis; and Fluvirin™, a triple-antigen flu vaccine, approved for sale in more than 20 countries.
MedImmune in Speke is focused on using biotechnology to produce innovative products and this site provides a significant volume of their biomanufacturing capability for Flumist™.